WESTON, Fla., April 26, 2023 /PRNewswire/ – Apotex Corp. has expanded its oncology product portfolio with the launch of Bendamustine hydrochloride injection in the United States. Bendamustine hydrochloride injection is an alkylating drug approved by the FDA for treatment of patients with…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.